Monofer 100 mg/ml raztopina za injiciranje/infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

monofer 100 mg/ml raztopina za injiciranje/infundiranje

železo - raztopina za injiciranje/infundiranje - železo 100 mg / 1 ml - zdravila z železom za parenteralno uporabo

Monofer 100 mg/ml raztopina za injiciranje/infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

monofer 100 mg/ml raztopina za injiciranje/infundiranje

železo - raztopina za injiciranje/infundiranje - železo 100 mg / 1 ml - zdravila z železom za parenteralno uporabo

Monofer 100 mg/ml raztopina za injiciranje/infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

monofer 100 mg/ml raztopina za injiciranje/infundiranje

železo - raztopina za injiciranje/infundiranje - železo 100 mg / 1 ml - zdravila z železom za parenteralno uporabo

Galvus Evropska unija - slovenščina - EMA (European Medicines Agency)

galvus

novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Zomarist Evropska unija - slovenščina - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, metformin hidroklorid - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Xiliarx Evropska unija - slovenščina - EMA (European Medicines Agency)

xiliarx

novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).